CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

作者：Michael G. Pfreundschuh, Lorenz H. P. Trümper, Anders Österborg, Ruth Pettengell, Marek Trněný, Kevin Imrie, Dávid Ma, Devinder Singh Gill, Jan Andrzej Walewski, Pier Luigi Zinzani, Rolf Arno Stahel, Stein Kvaløy, Ofer Shpilberg, Ulrich Jaeger, Mads Hansen, Tuula Lehtinen, Armando López‐Guillermo, Claudia Corrado, Adriana Alves de Souza Scheliga, Noel Jean Milpied, Myriam Mendila, Michelle Rashford, Evelyn Kuhnt, Markus W. Loeffler · 发表于：The Lancet Oncology · 年份：2006 · DOI：10.1016/s1470-2045(06)70664-7 · 被引用次数：2099 · 研究领域：Lymphoma Diagnosis and Treatment、CNS Lymphoma Diagnosis and Treatment、Acute Lymphoblastic Leukemia research